Lauren Jackson is an associate in the firm's Complex Litigation and Dispute Resolution practice. Her practice focuses on complex commercial disputes, securities litigation, and M&A disputes. Ms. Jackson also counsels clients on regulatory compliance, regulatory inquiries, and regulatory disclosures. She joined Goodwin in 2020.
Ms. Jackson’s recent representations include:
- Representing a clinical trial SAAS company in M&A litigation over post-acquisition earnout payments.
- Defending a content delivery network service provider in connection with various shareholder litigations arising out of an all-stock acquisition and merger.
- Representing a global alternative investment firm in trade secrets litigation involving one of the firm’s portfolio companies.
- Representing an early-stage venture capital fund in a dispute stemming from sale of equity interests in a tech startup company.
- Defending a pharmaceutical company from antitrust allegations stemming from its defense of patents protecting a brand-name medication.
- Representation of various pharmaceutical and tech companies in stock-drop securities litigation.
- Representation of various pharmaceutical, tech, and biotech companies in SEC and FINRA investigations.
Areas of Practice
Duke University School of Law
- U.S. District Court for the District of Massachusetts
Recognition & Awards
While attending law school, Ms. Jackson was an associate editor for Law & Contemporary Problems and a symposium editor for the Duke Environmental Law & Policy Forum. She was a two-time semifinalist in the Dean’s Cup appellate advocacy competition, and was the 2020 recipient of the Justin Miller Award for Intellectual Curiosity.